Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Red elm bark (Ulmus rubra), commonly known as slippery elm, contains arabinoxylan and rhamnogalacturonan mucilage polysaccharides that hydrate into a viscous demulcent gel, physically coating and protecting inflamed epithelial surfaces of the gastrointestinal and respiratory tracts. Manville et al. (2022) further demonstrated that tannins isolated from U. rubra bark activate KCNQ5 potassium channels to produce vasorelaxation, providing a molecular mechanism for its traditional cardiovascular applications in Native American medicine (PMID 35997997).
Reported Benefits (Provisional)
Origin & History
Ulmus rubra, commonly known as Red Elm or Slippery Elm, is a deciduous tree native to Eastern and Central North America, spanning the United States and Canada. Its inner bark is rich in mucilage, making it a valuable functional ingredient for soothing mucous membranes and supporting digestive and respiratory health.
Research Narrative (Provisional)
Manville et al. (2022) in FASEB Journal demonstrated that tannins from Ulmus rubra bark activate KCNQ5 potassium channels, inducing vasorelaxation in vascular smooth muscle and providing a mechanistic rationale for cardiovascular uses in Native American botanical medicine (PMID 35997997). Brown et al. (2004) in Alternative Medicine Review described five psoriasis case reports in which medical nutrition therapy incorporating slippery elm bark as a demulcent gut-healing agent contributed to measurable improvements in Psoriasis Area and Severity Index (PASI) scores (PMID 15387720). Slippery elm bark has also been investigated as a component of Essiac, a multi-herb formula reviewed for potential anticancer properties, though controlled clinical evidence for efficacy remains insufficient (PMID 11365626). Tinsley et al. (2019) in the Journal of Dietary Supplements found that a purported detoxification supplement containing slippery elm did not significantly improve body composition, waist circumference, blood markers, or gastrointestinal symptoms in healthy adult females (n=34), highlighting the need for rigorous trials of multi-ingredient formulas (PMID 29958034).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Mucilage, flavonoids (quercetin, kaempferol), tannins, polyphenols. - Minerals: Calcium, magnesium, potassium.
Reported Mechanism (Provisional)
The inner bark of Ulmus rubra is rich in arabinoxylan and rhamnogalacturonan mucilage polysaccharides that swell extensively upon hydration, forming a viscous gel that physically coats inflamed epithelial surfaces in the gastrointestinal and respiratory tracts, reducing contact-mediated irritation and stimulating reflex secretion of protective mucus via afferent nerve stimulation. This demulcent barrier decreases transepithelial permeability, which may help limit antigen translocation and secondary inflammatory signaling through NF-κB pathways in the gut mucosa. Additionally, Manville et al. (2022) identified that bark-derived tannins — including procyanidins and ellagitannins — act as direct activators of KCNQ5 (Kv7.5) voltage-gated potassium channels in vascular smooth muscle, hyperpolarizing the membrane and producing endothelium-independent vasorelaxation (PMID 35997997). The bark also contains antioxidant phenolic compounds, including catechins and flavonoids, that scavenge reactive oxygen species and may attenuate oxidative stress at sites of mucosal inflammation.
Clinical Narrative (Provisional)
Human clinical trials specifically on Ulmus rubra are limited, with most research conducted on related elm species. In 80 patients with elevated LDL-C, Ulmus macrocarpa extract (500 mg daily for 12 weeks) reduced LDL cholesterol by 23 mg/dL versus 9 mg/dL in placebo group, with no reported side effects. A safety study in 50 healthy adults found no changes in liver or renal function markers after 4 weeks of treatment. Evidence for red elm bark's traditional uses relies primarily on in vitro studies, animal models, and historical usage patterns rather than robust human clinical data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.